Rheumatoid arthritis and periodontitis; a possible link via citrullination

Anaerobe

Volumn 17, Issue 4, 2011, Pages 196-200

  De Smit, M J ^a   Brouwer, E ^a   Vissink, A ^a   Van Winkelhoff, A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Periodontitis; Porphyromonas gingivalis; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 1; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN ARGININE DEIMINASE; RHEUMATOID FACTOR;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTHRITIS, RHEUMATOID; CITRULLINE; HUMANS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RISK FACTORS;

PORPHYROMONAS GINGIVALIS;

EID: 80051927938     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.03.019     Document Type: Article

References (68)

1. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999, 4:1-6.
2. Jansson H. Studies on periodontitis and analyses of individuals at risk for periodontal diseases. Swed Dent J Suppl 2006, 5-49.
3. van Winkelhoff A.J., Loos B.G., van der Reijden W.A., van der Velden U. Porphyromonas gingivalis, bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol 2002, 29:1023-1028.
4. van der Velden U., Abbas F., Armand S., Loos B.G., Timmerman M.F., Van der Weijden G.A. Java project on periodontal diseases. The natural development of periodontitis: risk factors, risk predictors and risk determinants. J Clin Periodontol 2006, 33:540-548.
5. Albandar J.M., Streckfus C.F., Adesanya M.R., Winn D.M. Cigar, pipe, and cigarette smoking as risk factors for periodontal disease and tooth loss. J Periodontol 2000, 71:1874-1881.
6. Peruzzo D.C., Benatti B.B., Ambrosano G.M., Nogueira-Filho G.R., Sallum E.A., Casati M.Z. A systematic review of stress and psychological factors as possible risk factors for periodontal disease. J Periodontol 2007, 78:1491-1504.
7. Haffajee A.D., Socransky S.S., Lindhe J., Kent R.L., Okamoto H., Yoneyama T. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol 1991, 18:117-125.
8. Skaleric U., Kovac-Kavcic M. Some risk factors for the progression of periodontal disease. J Int Acad Periodontol 2000, 2:19-23.
9. Stanford T.W., Rees T.D. Acquired immune suppression and other risk factors/indicators for periodontal disease progression. Periodontol 2003, 2000(32):118-135.
10. Chaffee B.W., Weston S.J. The association between chronic periodontal disease and obesity: a systematic review with meta-analysis. J Periodontol 2010.
11. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999, 138:S534-S536.
12. Madianos P.N., Lieff S., Murtha A.P., Boggess K.A., Auten R.L., Beck J.D. Maternal periodontitis and prematurity. Part II: maternal infection and fetal exposure. Ann Periodontol 2001, 6:175-182.
13. van Winkelhoff A.J., Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol. 2000 1999, 20:122-135.
14. Beck J.D., Offenbacher S. Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease. J Periodontol 2005, 76:2089-2100.
15. D'Aiuto F., Parkar M., Brett P.M., Ready D., Tonetti M.S. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine 2004, 28:29-34.
16. Southerland J.H., Taylor G.W., Moss K., Beck J.D., Offenbacher S. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol. 2000 2006, 40:130-143.
17. Mealey B.L., Oates T.W. Diabetes mellitus and periodontal diseases. J Periodontol 2006, 77:1289-1303.
18. Scannapieco F.A., Bush R.B., Paju S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 2003, 8:38-53.
19. Berthelot J.M., Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine 2010.
20. Nesse W., Dijkstra P.U., Abbas F., Spijkervet F.K., Stijger A., Tromp J.A. Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol 2010, 81:1622-1628.
21. Brito F., de Barros F.C., Zaltman C., Carvalho A.T., Carneiro A.J., Fischer R.G. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol 2008, 35:555-560.
22. Khader Y.S., Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis. J Periodontol 2005, 76:161-165.
23. Tobon G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. J Autoimmun 2010, 35:10-14.
24. Vossenaar E.R., van Venrooij W.J. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 2004, 6:107-111.
25. van der Woude D., Houwing-Duistermaat J.J., Toes R.E., Huizinga T.W., Thomson W., Worthington J. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009, 60:916-923.
26. Kallberg H., Ding B., Padyukov L., Bengtsson C., Ronnelid J., Klareskog L. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011, 70:508-511.
27. Nielen M.M., van S.D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
28. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
29. van der Helm-van Mil A.H., Verpoort K.N., Breedveld F.C., Toes R.E., Huizinga T.W. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005, 7:R949-R958.
30. Steiner G., Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 2002, 4(Suppl. 2):S1-S5.
31. Nienhuis R., Mandema E. A new serum factor in patients with rheumatoid arthritis; the anti perinuclear factor. Ann Rheum Dis 1964, 23:302-305.
32. van Venrooij W.J., Vossenaar E.R., Zendman A.J. Anti-CCP antibodies: the new rheumatoid factor in the serology of rheumatoid arthritis. Autoimmun Rev 2004, 3(Suppl. 1):S17-S19.
33. Vossenaar E.R., Radstake T.R., van der H.A., van Mansum M.A., Dieteren C., de Rooij D.J. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004, 63:373-381.
34. Makrygiannakis D., Hermansson M., Ulfgren A.K., Nicholas A.P., Zendman A.J., Eklund A. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 67:1488-1492.
35. Nesse W., Westra J., van der Wal E., Balsma F., Abbas F., Brouwer E. The periodontium contains citrullinated proteins, PAD-2 enzymes and HC Gp-39 2009, Abstract 1165 ACR/ARHP 2009 Abstract 1165 ACR/ARHP 2009[Abstract 1165 ACR/ARHP 2009], Abstract 1165 ACR/ARHP, 10-19-2009. Ref Type: Abstract.
36. Kinloch A., Lundberg K., Wait R., Wegner N., Lim N.H., Zendman A.J. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008, 58:2287-2295.
37. Hendler A., Mulli T.K., Hughes F.J., Perrett D., Bombardieri M., Houri-Haddad Y. Involvement of autoimmunity in the pathogenesis of aggressive periodontitis. J Dent Res 2010, 89:1389-1394.
38. Smolik I., Robinson D., El-Gabalawy H.S. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations. Compend Contin Educ Dent 2009, 30:188-190. 192, 194.
39. Ortiz P., Bissada N.F., Palomo L., Han Y.W., Al-Zahrani M.S., Panneerselvam A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009, 80:535-540.
40. Bradford Hill A. The environment and disease: association or Causation?. Proc Royal Soc Med 1965, 58:295-300.
41. de Pablo P., Dietrich T., McAlindon T.E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008, 35:70-76.
42. Mercado F.B., Marshall R.I., Klestov A.C., Bartold P.M. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001, 72:779-787.
43. Kasser U.R., Gleissner C., Dehne F., Michel A., Willershausen-Zonnchen B., Bolten W.W. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997, 40:2248-2251.
44. Tolo K., Jorkjend L. Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis. J Clin Periodontol 1990, 17:288-291.
45. Mercado F., Marshall R.I., Klestov A.C., Bartold P.M. Is there a relationship between rheumatoid arthritis and periodontal disease?. J Clin Periodontol 2000, 27:267-272.
46. Nesse W., Abbas F., van, I d.P., Spijkervet F.K., Dijkstra P.U., Vissink A. periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008, 35:668-673.
47. Mikuls T.R., Payne J.B., Reinhardt R.A., Thiele G.M., Maziarz E., Cannella A.C. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol 2009, 9:38-42.
48. Moen K., Brun J.G., Madland T.M., Tynning T., Jonsson R. Immunoglobulin G and A antibody responses to bacteroides forsythus and prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol 2003, 10:1043-1050.
49. Moen K., Brun J.G., Valen M., Skartveit L., Eribe E.K., Olsen I. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006, 24:656-663.
50. Martinez-Martinez R.E., bud-Mendoza C., Patino-Marin N., Rizo-Rodriguez J.C., Little J.W., Loyola-Rodriguez J.P. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009, 36:1004-1010.
51. Al-Katma M.K., Bissada N.F., Bordeaux J.M., Sue J., Askari A.D. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 2007, 13:134-137.
52. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46.
53. Hill J.A., Southwood S., Sette A., Jevnikar A.M., Bell D.A., Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003, 171:538-541.
54. Kallberg H., Padyukov L., Plenge R.M., Ronnelid J., Gregersen P.K., van der Helm-van Mil A.H. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007, 80:867-875.
55. Costenbader K.H., Chang S.C., De Vivo I., Plenge R., Karlson E.W. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther 2008, 10:R52.
56. Bonfil J.J., Dillier F.L., Mercier P., Reviron D., Foti B., Sambuc R. A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol 1999, 26:77-84.
57. Laine M.L., Loos B.G., Crielaard W. Gene polymorphisms in chronic periodontitis. Int J Dent 2010, 2010:324719.
58. Harrison P., Pointon J.J., Chapman K., Roddam A., Wordsworth B.P. Interleukin-1 p.omoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology. (Oxford) 2008, 47:1768-1770.
59. Laine M.L., Farre M.A., Gonzalez G., van Dijk L.J., Ham A.J., Winkel E.G. Polymorphisms of the interleukin-1 gene family, oral microbial pathogens, and smoking in adult periodontitis. J Dent Res 2001, 80:1695-1699.
60. McGuire M.K., Nunn M.E. Prognosis versus actual outcome. IV. The effectiveness of clinical parameters and IL-1 genotype in accurately predicting prognoses and tooth survival. J Periodontol 1999, 70:49-56.
61. van Steenbergen T.J., van Winkelhoff A.J., van der Velden U., de Graaff J. Taxonomy, virulence and epidemiology of black-pigmented bacteroides species in relation to oral infections. Infection 1989, 17:194-196.
62. Griffen A.L., Becker M.R., Lyons S.R., Moeschberger M.L., Leys E.J. Prevalence of porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998, 36:3239-3242.
63. McGraw W.T., Potempa J., Farley D., Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999, 67:3248-3256.
64. Shirai H., Blundell T.L., Mizuguchi K. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci 2001, 26:465-468.
65. Pancholi V., Fischetti V.A. Alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 1998, 273:14503-14515.
66. Wygrecka M., Marsh L.M., Morty R.E., Henneke I., Guenther A., Lohmeyer J. Enolase-1 p.omotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009, 113:5588-5598.
67. Lundberg K., Kinloch A., Fisher B.A., Wegner N., Wait R., Charles P. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008, 58:3009-3019.
68. Wegner N., Wait R., Sroka A., Eick S., Nguyen K.A., Lundberg K. Peptidylarginine deiminase from porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010.